Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Active not recruiting 9Recruiting 3Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Neoplasm Metastasis 1Carcinoma, Transitional Cell 1

Interventions

Specimen Handling 308Magnetic Resonance Spectroscopy 265pembrolizumab 254Carboplatin 185Cyclophosphamide 180Biopsy 168Cisplatin 157Gemcitabine 136Paclitaxel 131Bevacizumab 125fludarabine 118Nivolumab 111Radiotherapy 109Oxaliplatin 88Docetaxel 88Fluorouracil 85Capecitabine 84venetoclax 78Dexamethasone 77Pemetrexed 73Rituximab 70Leucovorin 69Drug Therapy 69durvalumab 67atezolizumab 67Radiosurgery 65Blood Specimen Collection 65Standard of Care 64Doxorubicin 64Radiation 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × gallium 68 PSMA-11 × 90 days × Clear all
NCT04886986 2026-06-11

Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer

Weill Medical College of Cornell University

Phase 1 Recruiting
42 enrolled
Genitourinary

Prostatic Neoplasms

NCT05562791 2026-04-22

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
20 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT06044857 2026-04-14

PSMA PET Response Guided SabR in High Risk Pca

University of Texas Southwestern Medical Center

Phase 1 Recruiting
20 enrolled
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡